Published in J Rheumatol on January 01, 2009
Update on peripheral ulcerative keratitis. Clin Ophthalmol (2012) 1.34
Infliximab for progressive peripheral ulcerative keratitis in a patient with juvenile rheumatoid arthritis. Jpn J Ophthalmol (2011) 0.84
New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet (2002) 2.39
Treatment of primary Sjögren syndrome with rituximab: a randomized trial. Ann Intern Med (2014) 2.36
BMI and mortality: results from a national longitudinal study of Canadian adults. Obesity (Silver Spring) (2009) 2.25
Online home self-assessment: a tool for improving future treatment trials? Joint Bone Spine (2012) 1.99
Gluteus tendon rupture is underrecognized by French orthopedic surgeons: results of a mail survey. Joint Bone Spine (2006) 1.69
Provocative sacroiliac joint maneuvers and sacroiliac joint block are unreliable for diagnosing sacroiliac joint pain. Joint Bone Spine (2006) 1.54
IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore) (2012) 1.54
Diagnostic accuracy of ACR/EULAR 2010 criteria for rheumatoid arthritis in a 2-year cohort. J Rheumatol (2011) 1.47
Body mass index in urban Canada: neighborhood and metropolitan area effects. Am J Public Health (2007) 1.45
Comparing health and health care use in Canada and the United States. Health Aff (Millwood) (2006) 1.42
Socioeconomic status and utilization of health care services in Canada and the United States: findings from a binational health survey. Med Care (2009) 1.38
Changes over time in the diagnosis of rheumatoid arthritis in a 10-year cohort. J Rheumatol (2009) 1.37
Changes in unmet health care needs. Health Rep (2002) 1.28
Potential impact of population-based colorectal cancer screening in Canada. Chronic Dis Can (2003) 1.28
Lifetime costs of colon and rectal cancer management in Canada. Chronic Dis Can (2003) 1.28
Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. Rheumatology (Oxford) (2013) 1.28
Descriptive epidemiology of osteoarthritis in British Columbia, Canada. J Rheumatol (2006) 1.27
Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996. CMAJ (2004) 1.19
Regulatory B cells play a key role in immune system balance. Joint Bone Spine (2012) 1.16
Determinants of unacceptable waiting times for specialized services in Canada. Healthc Policy (2007) 1.16
Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res (Hoboken) (2014) 1.15
The predictive validity of health-related quality of life measures: mortality in a longitudinal population-based study. Qual Life Res (2007) 1.10
Trends in socioeconomic disparities in health care quality in four countries. Int J Qual Health Care (2007) 1.07
Deriving utility scores for co-morbid conditions: a test of the multiplicative model for combining individual condition scores. Popul Health Metr (2006) 1.06
Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature. Joint Bone Spine (2008) 1.05
The Hawthorne effect: stronger than the placebo effect? Joint Bone Spine (2011) 1.04
Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences. Arthritis Rheum (2009) 1.04
Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial. Arthritis Rheum (2009) 1.03
From osteoarthritis treatments to future regenerative therapies for cartilage. Drug Discov Today (2009) 1.02
Eliciting Canadian population preferences for health states using the Classification and Measurement System of Functional Health (CLAMES). Chronic Dis Can (2007) 1.01
Estimating summary measures of health: a structured workbook approach. Popul Health Metr (2005) 1.00
New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases. Semin Arthritis Rheum (2011) 0.97
Gender differences in disability-free life expectancy for selected risk factors and chronic conditions in Canada. J Women Aging (2002) 0.97
Suspected disk space infection with negative microbiological tests-report of eight cases and comparison with documented pyogenic discitis. Joint Bone Spine (2005) 0.97
TNF alpha antagonist therapy and safety monitoring. Joint Bone Spine (2011) 0.96
Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study. Arthritis Res Ther (2010) 0.96
Feasibility and safety of ultrasound-guided caudal epidural glucocorticoid injections. Joint Bone Spine (2010) 0.95
A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis. Arthritis Res Ther (2009) 0.94
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry. Ann Rheum Dis (2012) 0.93
Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis. Joint Bone Spine (2010) 0.93
Premature mortality in health regions with high aboriginal populations. Health Rep (2004) 0.92
Papilloedema and MRI enhancement of the prechiasmal optic nerve at the acute stage of Leber hereditary optic neuropathy. J Neurol Neurosurg Psychiatry (2010) 0.91
Side effects of corticosteroid injections: what's new? Joint Bone Spine (2013) 0.91
Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series. Joint Bone Spine (2011) 0.91
Modified deep anterior lamellar keratoplasty in the management of small and large epithelialized descemetoceles. Cornea (2011) 0.90
New pathogenic hypotheses for spondyloarthropathies. Joint Bone Spine (2002) 0.88
CIHI survey: Hospital costs for preterm and small-for-gestational age babies in Canada. Healthc Q (2009) 0.88
Tocilizumab in refractory adult Still's disease. Arthritis Care Res (Hoboken) (2011) 0.88
Contribution of centralization phenomenon to the diagnosis, prognosis, and treatment of diskogenic low back pain. Joint Bone Spine (2007) 0.88
Performance of the polymyalgia rheumatica activity score for diagnosing disease flares. Arthritis Rheum (2008) 0.87
Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients. Pediatr Infect Dis J (2010) 0.87
Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry). Ann Rheum Dis (2012) 0.87
Whipple's disease diagnosed during biological treatment for joint disease. Joint Bone Spine (2010) 0.86
Characterization of the age-dependent intervertebral disc changes in rabbit by correlation between MRI, histology and gene expression. BMC Musculoskelet Disord (2011) 0.85
Clinical utility of serum bone turnover markers in postmenopausal osteoporosis therapy monitoring: a systematic review. Semin Arthritis Rheum (2011) 0.83
Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study. Chest (2013) 0.83
Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy. Joint Bone Spine (2006) 0.83
Endoneural metastasis of the sciatic nerve disclosing the relapse of a renal carcinoma, four years after its surgical treatment. Joint Bone Spine (2006) 0.83
High intraindividual week-to-week variability in BASDAI and BASFI values: are several evaluations needed before starting or stopping TNFalpha antagonist therapy for spondyloarthropathies? Joint Bone Spine (2008) 0.83
Second-line drugs used in recent-onset rheumatoid arthritis in Brittany (France). Joint Bone Spine (2002) 0.82
[Nutrition and osteoporosis in elderly]. Geriatr Psychol Neuropsychiatr Vieil (2011) 0.82
Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis. J Clin Virol (2013) 0.82
Visual impairment and hip fractures: a case-control study in elderly patients. Ophthalmic Res (2014) 0.82
Impaired saccadic eye movement in primary open-angle glaucoma. J Glaucoma (2014) 0.82
Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice. J Rheumatol (2011) 0.81
Assessment of calcific tendonitis of rotator cuff by ultrasonography: comparison between symptomatic and asymptomatic shoulders. Joint Bone Spine (2010) 0.81
Osteoclasts in RA: diverse origins and functions. Joint Bone Spine (2013) 0.81
Population health impact of cancer in Canada, 2001. Chronic Dis Can (2007) 0.81
Never too old to harbour a young man's disease? Br J Ophthalmol (2011) 0.81
Treatment responses in five patients with Ribbing disease including two with 466C>T missense mutations in TGFβ1. Joint Bone Spine (2013) 0.81
Rheumatoid arthritis and sexuality: a patient survey in France. BMC Musculoskelet Disord (2012) 0.80
Outcome and safety of TNFα antagonist therapy in 475 consecutive outpatients (with rheumatoid arthritis or spondyloarthropathies) treated by a single physician according to their eligibility for clinical trials. Joint Bone Spine (2010) 0.80
Weekly home self-assessment of RAPID-4/3 scores in rheumatoid arthritis: a 6-month study in 26 patients. Joint Bone Spine (2010) 0.80
Treatment of shoulder calcifications of the cuff: a controlled study. Joint Bone Spine (2009) 0.80
Information on glucocorticoid therapy in the main studies of biological agents. Joint Bone Spine (2011) 0.80
Three-dimensional versus two-dimensional ultrasonographic assessment of peripheral enthesitis in spondylarthritis. Clin Rheumatol (2013) 0.80
Lasting remission of a Muckle-Wells syndrome with CIAS-1 mutation using half-dose anakinra. Joint Bone Spine (2007) 0.80
Patient knowledge of their disease: a French multicenter study in ankylosing spondylitis. Joint Bone Spine (2004) 0.79
Comparison of ACR 1987 and ACR/EULAR 2010 criteria for predicting a 10-year diagnosis of rheumatoid arthritis. Joint Bone Spine (2012) 0.79
Pathogenesis of hyperostosis: a key role for mesenchymatous cells? Joint Bone Spine (2013) 0.79
The role for radicular veins in nerve root pain is underestimated: limitations of imaging studies. Joint Bone Spine (2011) 0.79